Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors.
Ishi Y, Zhang Y, Zhang A, Sasaki T, Piunti A, Suri A, Watanabe J, Abe K, He X, Katagi H, Bhalla P, Natsumeda M, Zou L, Shilatifard A, Hashizume R.
Ishi Y, et al. Among authors: zhang a, zhang y.
Mol Cancer Ther. 2022 May 4;21(5):715-726. doi: 10.1158/1535-7163.MCT-21-0646.
Mol Cancer Ther. 2022.
PMID: 35247919
Free PMC article.